“We contracted Oxeltis services in order to enhance/modify emissive and absorption spectrum properties of a reagent in our innovative diagnostic kit.Oxeltis team understood immediately our needs and proposed us an innovative optimization approach that paid off quickly. After 3 months we had reached our goals for this new reagent. Therefore, we strongly recommend OXELTIS for their professionalism and their ability to solve complex optimization of physico-chemical properties of small molecules.”Henri Champseix, Co-founder and CTO, BIT-C2 Diagnostics.
“What we really appreciated with Oxeltis is the follow-up that the company provides all along the synthesis process and even after. They really care about the quality of the service: they contact you to keep you updated about the production, and want to make sure you are satisfied once the product has been delivered. We have been extremely satisfied with this company and strongly recommend it.” Dr Olivier Chassande, CNRS, Laboratoire de Bioingénierie Tissulaire (BioTis), Université Bordeaux Ségalen, France »
“We contracted Oxeltis to synthesize a lead compound which proved problematic for others. In meeting with the Oxeltis team we walked away very confident that they could handle the synthesis and deliver based on our timeline needs. The Oxeltis team exceeded our expectations. We are extremely satisfied and highly recommend them for your synthesis and medicinal chemistry needs .” Dr. Olumide Kayode, CEO, Geminus Therapeutics an Early Charm Ventures company. Baltimore – MD, USA
Other clients and programs in Europe and North America are currently confidential.